You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Médicaments

La bibliothèque de médicaments donne accès à des renseignements sur plus de 100 médicaments anticancéreux commercialisés au Canada.

Trouvez plus d’information sur la sécurité  dans le document patient supplémentaire Comment prendre vos médicaments oraux contre le cancer de manière sécuritaire.

Displaying Drugs List

10 Items
Other Name(s): Avastin®; Mvasi™; Zirabev™
Funding:
New Drug Funding Program
  • Bevacizumab (Biosimilar) - First Line - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer
  • Bevacizumab (Biosimilar) - Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
  • Bevacizumab (Biosimilar) with Paclitaxel and Carboplatin - Front-line Treatment (Previously Untreated) Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
  • Bevacizumab (Biosimilar) for Platinum-Resistant Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Dec 2019
Nov 2019
Updated
Feb 2020
Other Name(s): Vepesid®
Funding:
ODB - General Benefit
  • etoposide - oral capsules
Sep 2019
Other Name(s): Camptosar® ()
Funding:
New Drug Funding Program
  • Irinotecan - First Line - Metastatic Colorectal Small Bowel or Appendiceal Cancer
  • Irinotecan - Second Line - Metastatic Colorectal Small Bowel or Appendiceal Cancer
Jan 2019
Other Name(s): CeeNU®
Funding:
ODB - General Benefit
  • lomustine
Jun 2019
Other Name(s): Matulane®
Funding:
ODB - General Benefit
  • procarbazine
Dec 2019
Other Name(s): Temodal®
Funding:
ODB Limited Use
  • temozolomide - Newly diagnosed glioblastoma multiforme (concurrent radiotherapy then maintenance)
  • temozolomide - Recurrent or progressive glioblastoma multiforme or anaplastic astrocytoma
Sep 2019
Other Name(s): Velban® (multiple brands available)
May 2018
Other Name(s): Oncovin® (multiple brands available)
Nov 2017